The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus
Open accessAbstract
Type 2 diabetes mellitus is a common disabling disease with onset in middle-aged individuals, caused by an imbalance between insulin production and action. Genetic studies point to major genetic components, but, with the exception of maturity-onset diabetes of the young (MODY), specific diabetes susceptibility genes remain to be identified. Recent studies showed that a dominant negative mutation in the insulin promoter factor-1 (IPF-1), a pancreatic beta-cell specific transcription factor, causes pancreatic agenesis and MODY. Thus, we investigated 192 French, non-MODY type 2 diabetic families for mutations in IPF-1. We identified 3 novel IPF-1 mutations, including 2 substitutions (Q59L and D76N) and an in-frame proline insertion (InsCCG243). Functional transactivation assays of these IPF-1 mutant isoforms in a beta-pancreatic tumor cell line transfected with a transcriptional reporter and IPF-1 expression plasmids demonstrate a significant inhibition of basal insulin promoter activity (stronger with the InsCCG243 mutant). We find that the InsCCG243 mutation is linked, in 2 families, to an autosomal dominant-like late-onset form of type 2 diabetes, in which insulin secretion becomes progressively impaired. The lower penetrance D76N and Q59L mutations were more prevalent and were associated with a relative risk of 12.6 for diabetes and with decreased glucose-stimulated insulin-secretion in nondiabetic subjects. We propose that IPF-1 mutations can cause MODY or apparently monogenic late-onset diabetes and that they represent a significant risk factor for type 2 diabetes in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin-promoter-factor 1 is required for pancreas development in mice
Jonsson, J., Carlsson, L., Edlund, T., & Edlund, H. (1994) · Nature · doi:10.1038/371606a0 · Cited by 1,785
Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
Yamagata, K., Oda, N., Kaisaki, P. J., Menzel, S., Furuta, H., Vaxillaire, M., Southam, L., Cox, R. D., Lathrop, G. M., Boriraj, V. V., et al. (1996) · Nature · doi:10.1038/384455a0 · Cited by 1,614
Self-citationStoffers, D. A., Zinkin, N. T., Stanojevic, V., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng0197-106 · Cited by 1,106
Self-citationMutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1)
Yamagata, K., Furuta, H., Oda, N., Kaisaki, P. J., Menzel, S., Cox, N. J., Fajans, S. S., Signorini, S., Stoffel, M., & Bell, G. I. (1996) · Nature · doi:10.1038/384458a0 · Cited by 976
Ahlgren, U., Jonsson, J., Jonsson, L., Simu, K., & Edlund, H. (1998) · Genes & Development · doi:10.1101/gad.12.12.1763 · Cited by 918
Early-onset type-ll diabetes mellitus (MODY4) linked to IPF1
Staffers, D. A., Ferrer, J., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng1097-138 · Cited by 882
Self-citationMutation in hepatocyte nuclear factor–1β gene (TCF2) associated with MODY
Horikawa, Y., Iwasaki, N., Hara, M., Furuta, H., Hinokio, Y., Cockburn, B. N., Lindner, T., Yamagata, K., Ogata, M., Tomonaga, O., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-384 · Cited by 880
Mermod, N., O'Neill, E. A., Kelly, T. J., & Tjian, R. (1989) · Cell · doi:10.1016/0092-8674(89)90108-6 · Cited by 764
Froguel, P., Zouali, H., Vionnet, N., Velho, G., Vaxillaire, M., Sun, F., Lesage, S., Stoffel, M., Takeda, J., Passa, P., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303113281005 · Cited by 735
Self-citation(1997) · Diabetes reviews · Cited by 671
Cited by
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
“GLP-1-induced stimulation of insulin synthesis is initiated by Pdx1, a transcription factor implicated in development of the pancreas [490] and in MODY type-4 diabetes [522,523].”
BackgroundSelf-citationMolecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123
Diabetes mellitus and genetically programmed defects in β-cell function
Bell, G. I., & Polonsky, K. S. (2001) · Nature · doi:10.1038/414788a · Cited by 475
“IPF-1 mutations have also been discovered in a small fraction of patients with typical adult-onset type 2 diabete”
BackgroundPerfetti, R. (2000) · Endocrinology · doi:10.1210/en.141.12.4600 · Cited by 442
The New Biology and Pharmacology of Glucagon
Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D., & Tschöp, M. H. (2017) · Physiological Reviews · doi:10.1152/physrev.00025.2016 · Cited by 419
“Pdx-1 is a transcription factor involved in pancreatic development (256) and, when mutated, leads to MODY-type 4 diabetes (259, 409).”
BackgroundIntercellular signals regulating pancreas development and function
Kim, S. K., & Hebrok, M. (2001) · Genes & Development · doi:10.1101/gad.859401 · Cited by 402
Minireview: Transcriptional Regulation in Pancreatic Development
Habener, J. F., Kemp, D. M., & Thomas, M. K. (2005) · Endocrinology · doi:10.1210/en.2004-1576 · Cited by 399
Self-citationReduction in Pancreatic Transcription Factor PDX-1 Impairs Glucose-stimulated Insulin Secretion
Brissova, M., Shiota, M., Nicholson, W. E., Gannon, M., Knobel, S. M., Piston, D. W., Wright, C. V. E., & Powers, A. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111272200 · Cited by 375
Murea, M., Ma, L., & Freedman, B. I. (2012) · The Review of Diabetic Studies · doi:10.1900/rds.2012.9.6 · Cited by 366
Increased islet apoptosis in Pdx1+/– mice
Johnson, J. D., Ahmed, N. T., Luciani, D. S., Han, Z., Tran, H., Fujita, J., Misler, S., Edlund, H., & Polonsky, K. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16537 · Cited by 342
Wiltshire, S., Hattersley, A. T., Hitman, G. A., Walker, M., Levy, J. C., Sampson, M., O’Rahilly, S., Frayling, T. M., Bell, J. I., Lathrop, G. M., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/323249 · Cited by 305
Frayling, T. M., Evans, J. C., Bulman, M. P., Pearson, E., Allen, L., Owen, K., Bingham, C., Hannemann, M., Shepherd, M., Ellard, S., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s94 · Cited by 276
Glucose Regulation of Gene Transcription
Vaulont, S., Vasseur-Cognet, M., & Kahn, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000016200 · Cited by 267
Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function
McKinnon, C. M., & Docherty, K. (2001) · Diabetologia · doi:10.1007/s001250100628 · Cited by 257
Oliver-Krasinski, J. M., Kasner, M. T., Yang, J., Crutchlow, M. F., Rustgi, A. K., Kaestner, K. H., & Stoffers, D. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37028 · Cited by 177
Self-citationInsights on pathogenesis of type 2 diabetes from MODY genetics
Weedon, M. N., & Frayling, T. M. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0022-6 · Cited by 13
Metadata
- Authors
- Hani, E. H., Stoffers, D. A., Chèvre, J.-C., Durand, E., Stanojevic, V., Dina, C., Habener, J. F., & Froguel, P.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-11-01
- Volume
- 104
- Issue
- 9
- Pages
- R41-R48
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2104458426
- Cited by
- 281
- References
- 24
- FWCI
- 24.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.